Subcellular organization and Ca+2 signaling in heart failure
心力衰竭中的亚细胞组织和 Ca 2 信号传导
基本信息
- 批准号:6662945
- 负责人:
- 金额:$ 22.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-09-01 至 2007-08-31
- 项目状态:已结题
- 来源:
- 关键词:biological signal transduction calcium channel calcium flux calcium indicator cardiac myocytes confocal scanning microscopy cytoskeletal proteins gene targeting genetically modified animals heart failure laboratory mouse laboratory rat membrane potentials neuromuscular transmission protein structure function tissue /cell culture voltage /patch clamp
项目摘要
DESCRIPTION (provided by applicant):
Ca2+ signaling dysfunction occurs in heart muscle under many conditions and is associated
with diverse cardiac pathologies. This project seeks to characterize quantitatively Ca2+
signaling defects that occur in cardiac ventricular myocytes and to investigate the causes of
the dysfunction. Confocal Ca2+ imaging of single ventricular myocytes will be carried out to
measure Ca2+ sparks and the cellular Ca2+ signal at high temporal and spatial resolution.
Intracellular Ca2+ will be rapidly changed by photorelease of caged Ca2+ while membrane
potential is controlled with a whole cell patch clamp method. The planned experiments will
reveal the links between the Ca2+ current, the Ca2+ sparks and other components of the Ca2+
signal.
Preliminary experiments suggest a central hypothesis: a disruption of the machinery of
excitation-contraction coupling may underlie the Ca2+ signaling defects that have been
observed. Such remodeling may involve reorganization of the cytoskeletal proteins, altered
positioning of L-type Ca2+ channel proteins and/or the ryanodine receptor Ca2+ release
channels or re-organization of the transverse-tubules. To investigate the hypothesis, transgenic
mice, rat models of disease and new cell culture methods will be used to examine the
molecular causes of the Ca2+ signaling defects. Specific experiments will be carried out to
characterize the role of cytoskeletal elements in the Ca2+ signaling defects.
The planned work should therefore broaden our understanding of Ca2+ signaling in heart and
clarify how it may become dysfunctional in disease. Additionally, the work should provide
insight into the subcellular organization of the heart cell and illuminate the links between
transverse tubules, cytoskeletal structures, and voltage- and ligand-gated channels.
描述(由申请人提供):
钙信号转导功能障碍在许多情况下发生在心肌中,并与
心脏疾病多种多样。这个项目试图定量地表征钙离子
发生在心肌细胞中的信号缺陷,并探讨其原因
功能障碍。将对单个心室肌细胞进行共聚焦钙离子成像
测量高时间和空间分辨率的钙火花和细胞内的钙信号。
细胞内钙离子通过笼状钙离子的光释放而迅速变化,而膜
用全细胞膜片钳方法控制电压。计划中的实验将
揭示钙电流、钙火花和钙离子其他成分之间的联系
信号。
初步实验提出了一个中心假说:
兴奋-收缩偶联可能是钙离子信号缺陷的基础
观察到的。这种重塑可能涉及细胞骨架蛋白的重组,改变
L型钙通道蛋白的定位和/或兰尼定受体钙释放
横管的通道或重新组织。为了验证这一假设,转基因
将使用小鼠、大鼠疾病模型和新的细胞培养方法来检测
钙信号缺陷的分子原因。将开展具体试验,以
描述细胞骨架元素在钙信号缺陷中的作用。
因此,计划中的工作应该会拓宽我们对心脏和心脏中钙信号转导的理解
阐明它是如何在疾病中变得功能失调的。此外,这项工作应该提供
深入了解心脏细胞的亚细胞结构,并阐明
横管、细胞骨架结构、电压门控和配基门控通道。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William Jonathan Lederer其他文献
William Jonathan Lederer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William Jonathan Lederer', 18)}}的其他基金
Chemo-mechanical signaling in atrial myocytes
心房肌细胞中的化学机械信号传导
- 批准号:
10323655 - 财政年份:2019
- 资助金额:
$ 22.65万 - 项目类别:
Chemo-mechanical signaling in atrial myocytes
心房肌细胞中的化学机械信号传导
- 批准号:
10064006 - 财政年份:2019
- 资助金额:
$ 22.65万 - 项目类别:
Decreased Cholinergic Tone and Mitochondrial Dysfunction in Heart
心脏胆碱能张力降低和线粒体功能障碍
- 批准号:
8327739 - 财政年份:2011
- 资助金额:
$ 22.65万 - 项目类别:
Decreased Cholinergic Tone and Mitochondrial Dysfunction in Heart
心脏胆碱能张力降低和线粒体功能障碍
- 批准号:
8585942 - 财政年份:2011
- 资助金额:
$ 22.65万 - 项目类别:
Decreased Cholinergic Tone and Mitochondrial Dysfunction in Heart
心脏胆碱能张力降低和线粒体功能障碍
- 批准号:
8019904 - 财政年份:2011
- 资助金额:
$ 22.65万 - 项目类别:
相似海外基金
L-type Calcium Channel SNP rs1006737: characterizing the genetic risks in MUD (Methamphetamine Use Disorder)
L 型钙通道 SNP rs1006737:表征 MUD(甲基苯丙胺使用障碍)的遗传风险
- 批准号:
10668210 - 财政年份:2023
- 资助金额:
$ 22.65万 - 项目类别:
Development of a Novel Calcium Channel Therapeutic for the Treatment of Asthma
开发治疗哮喘的新型钙通道疗法
- 批准号:
10603554 - 财政年份:2023
- 资助金额:
$ 22.65万 - 项目类别:
Development of a Novel Calcium Channel Therapeutic for Opioid Use Disorder
开发一种治疗阿片类药物使用障碍的新型钙通道疗法
- 批准号:
10684558 - 财政年份:2023
- 资助金额:
$ 22.65万 - 项目类别:
Development of a Novel Medication for Alcohol Use Disorder with an Active IND Dual Inhibitor of T-Type Calcium Channel and Soluble Epoxide Hydrolase
使用 T 型钙通道和可溶性环氧化物水解酶的活性 IND 双重抑制剂开发治疗酒精使用障碍的新型药物
- 批准号:
10815882 - 财政年份:2023
- 资助金额:
$ 22.65万 - 项目类别:
Novel Tools to Probe Trafficking and Function of Calcium Channel Signaling Complexes in Heart
探测心脏钙通道信号复合物的运输和功能的新工具
- 批准号:
10628914 - 财政年份:2023
- 资助金额:
$ 22.65万 - 项目类别:
Mechanisms of L-type Calcium Channel Regulation in Heart Health and Disease
L 型钙通道在心脏健康和疾病中的调节机制
- 批准号:
10734121 - 财政年份:2023
- 资助金额:
$ 22.65万 - 项目类别:
Structure-Function of Calcium Channel Complexes in Cardiac Physiology and Disease
钙通道复合物在心脏生理和疾病中的结构-功能
- 批准号:
10628911 - 财政年份:2023
- 资助金额:
$ 22.65万 - 项目类别:
Research Initiation Award: Defining the role of DJ-1 in regulating L-type voltage-dependent calcium channel expression in neuronal plasticity
研究启动奖:定义 DJ-1 在调节神经元可塑性中 L 型电压依赖性钙通道表达中的作用
- 批准号:
2200474 - 财政年份:2022
- 资助金额:
$ 22.65万 - 项目类别:
Standard Grant
Design and Preclinical Development of First-in-Class Selective T-type Calcium Channel Blockers for Chronic Pain
用于治疗慢性疼痛的一流选择性 T 型钙通道阻滞剂的设计和临床前开发
- 批准号:
452107 - 财政年份:2021
- 资助金额:
$ 22.65万 - 项目类别:
Operating Grants
Preventing the Calcium Channel Blocker – Lower Extremity Edema – Loop Diuretic Prescribing Cascade in Older Adults
预防钙通道阻滞剂 – 下肢水肿 – 老年人袢利尿剂处方级联
- 批准号:
10399417 - 财政年份:2021
- 资助金额:
$ 22.65万 - 项目类别: